Navigation Links
Boca Pharmacal Contributes to a Healthier Haiti
Date:5/1/2013

CORAL SPRINGS, Fla., May 1, 2013 /PRNewswire/ -- Boca Pharmacal, Inc., today announced that it successfully donated 18,814 bottles of prescription multivitamins to Haiti in conjunction with Christian Aid Ministries, a nonprofit 501(c)(3) organization that helps the needy throughout the world. Perhaps more importantly, the company has also been successful in seeing that the products are getting to where they are needed – in clinics and hospitals on the island.  

(Photo: http://photos.prnewswire.com/prnh/20130501/FL05454-a)

(Logo: http://photos.prnewswire.com/prnh/20130501/FL05454LOGO-b)

"This has been a long time coming," said Robert Edwards , CEO of Boca Pharmacal. "After the earthquake hit Haiti in 2010, we felt compelled to help out and get medicine to the orphanages and clinics that were in need. The logistics turned out to be a tremendous challenge. The learning curve was high and it took time to figure out how to get the medication directly to the people who needed them the most. We've learned a lot about the supply chain and are encouraged about what we'll be able to do moving forward."

Boca Pharmacal is donating U.S. FDA-approved products that – while safe and effective – are typically destroyed by American companies because of limited dating or cosmetic imperfections.

"We see about 130 patients every day and vitamins are a large part of our therapy for those lacking in proper nutrition," said a representative of the Haiti Health Ministries in Leogane, Haiti. "One of our patients, Madame Dorelien, had been feeling weak lately and lacking in energy. The doctor prescribed a multivitamin for her. We are hopeful that this, in addition to eating properly, will bring her back to health."

Mr. Edwards is currently in the process of forming a nonprofit 501(c)(3) and is actively working with generic drug manufacturers to expand the program. He encourages other pharmaceutical companies interested in making large-scale pharmaceutical product donations to contact his team for information on how to participate.

Boca Pharmacal, Inc.
Since its beginnings in 1998, Boca Pharmacal's mission has been to offer niche items that were overlooked by some of the larger generic companies as affordable alternatives to brand-named products.

Using multiple facilities across the globe, Boca Pharmacal has a broad reach and a reliable vertical structure that allows them to develop products that include tablets and capsules, semi-solids, solutions, and suspensions. They continue to invest in research and development to make sure they're providing their clients with a wide variety of offerings. The Boca Pharmacal product line is marketed to chains, wholesalers, distributors, managed markets and government agencies. Boca Pharmacal is located at 3550 NW 126th Avenue, Coral Springs, Florida, 33065. For more information, visit www.bocapharmacal.com.

Images available upon request.CONTACT:

Jennifer MouraBoca Pharmacal3550 NW 126th AveCoral Springs, FL 33065Phone: (954) 346-8810Email: info@bocapharmacal.com


'/>"/>
SOURCE Boca Pharmacal, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mission Pharmacal Company Continues Its Support of March for Babies
2. Mission Pharmacal Company Introduces Prednisolone Sodium Phosphate Oral Solution 25mg/5mL
3. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
4. Texas A&M Research Contributes To Improved Ultrasound Imaging
5. Ansell and Child in Hand Announce Completion of Critical Community Projects in Haiti
6. Sae-A Trading Sponsors Medical Mission to Haiti
7. BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):